Jack Bendheim Sells 3,520 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 3,520 shares of the company’s stock in a transaction on Tuesday, November 4th. The stock was sold at an average price of $43.10, for a total value of $151,712.00. Following the completion of the sale, the chief executive officer owned 65,920 shares of the company’s stock, valued at $2,841,152. This trade represents a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Jack Bendheim also recently made the following trade(s):

• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.07, for a total value of $144,566.40.
• On Tuesday, October 28th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.56, for a total value of $146,291.20.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.18, for a total value of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.27, for a total value of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.38, for a total value of $649,108.50.
• On Friday, October 17th, Jack Bendheim sold 700 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.03, for a total value of $28,021.00.
• On Thursday, September 18th, Jack Bendheim sold 7,022 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.26, for a total value of $282,705.72.
• On Wednesday, September 10th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.29, for a total value of $145,340.80.
• On Tuesday, September 9th, Jack Bendheim sold 14,080 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.33, for a total value of $567,846.40.

Phibro Animal Health Price Performance

PAHC stock traded up $1.89 during trading on Thursday, reaching $43.04. The company’s stock had a trading volume of 411,364 shares, compared to its average volume of 276,804. Phibro Animal Health Corporation has a 1 year low of $16.16 and a 1 year high of $44.35. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46. The company has a market capitalization of $1.74 billion, a P/E ratio of 36.47, a price-to-earnings-growth ratio of 1.24 and a beta of 0.81. The company’s fifty day moving average is $39.58 and its 200-day moving average is $30.66.

Phibro Animal Health (NASDAQ:PAHC) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.73 EPS for the quarter, beating the consensus estimate of $0.58 by $0.15. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. The business had revenue of $363.89 million during the quarter, compared to the consensus estimate of $345.44 million. Phibro Animal Health has set its FY 2026 guidance at 2.640-2.810 EPS. On average, research analysts expect that Phibro Animal Health Corporation will post 1.95 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 17th. Shareholders of record on Wednesday, November 26th will be issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Wednesday, November 26th. Phibro Animal Health’s dividend payout ratio is 40.68%.

Analyst Upgrades and Downgrades

Several research firms have commented on PAHC. Weiss Ratings reissued a “hold (c)” rating on shares of Phibro Animal Health in a report on Tuesday, October 14th. Bank of America increased their price objective on shares of Phibro Animal Health from $19.00 to $27.00 and gave the company an “underperform” rating in a report on Friday, August 29th. Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Monday, September 29th. Finally, Morgan Stanley set a $34.00 price target on shares of Phibro Animal Health in a report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, Phibro Animal Health presently has a consensus rating of “Hold” and an average price target of $28.40.

Institutional Trading of Phibro Animal Health

Several institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in Phibro Animal Health by 0.4% in the first quarter. Vanguard Group Inc. now owns 1,521,520 shares of the company’s stock worth $32,500,000 after purchasing an additional 6,784 shares during the last quarter. Acadian Asset Management LLC lifted its stake in Phibro Animal Health by 0.5% in the first quarter. Acadian Asset Management LLC now owns 782,939 shares of the company’s stock worth $16,713,000 after purchasing an additional 4,144 shares during the last quarter. Geode Capital Management LLC lifted its stake in Phibro Animal Health by 1.4% in the second quarter. Geode Capital Management LLC now owns 554,927 shares of the company’s stock worth $14,175,000 after purchasing an additional 7,841 shares during the last quarter. Nuveen LLC bought a new stake in Phibro Animal Health in the first quarter worth about $10,312,000. Finally, Invesco Ltd. lifted its stake in Phibro Animal Health by 92.3% in the first quarter. Invesco Ltd. now owns 387,739 shares of the company’s stock worth $8,282,000 after purchasing an additional 186,087 shares during the last quarter. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.